{"id":3464,"date":"2014-02-25T04:45:59","date_gmt":"2014-02-25T04:45:59","guid":{"rendered":"https:\/\/www.cornerstone.com\/?post_type=case_study&p=3464"},"modified":"2023-12-08T08:20:05","modified_gmt":"2023-12-08T13:20:05","slug":"in-re-skelaxin-metaxalone-antitrust-litigation","status":"publish","type":"case_study","link":"https:\/\/www.cornerstone.com\/insights\/cases\/skelaxin-metaxalone-antitrust-litigation\/","title":{"rendered":"In re Skelaxin (Metaxalone) Antitrust Litigation"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","categories":[47,65],"tags":[],"asset_type":[79],"class_list":["post-3464","case_study","type-case_study","status-publish","hentry","category-antitrust-and-competition","category-life-sciences"],"acf":[],"yoast_head":"\n